Finding the PSA-based screening stopping age using prostate cancer risk
Background: Prostate Cancer screening was not rational for people who were suffered from other serious diseases and had a low quality of life. Biopsy and Prostate-Specific Antigen based screening also had imperfect information, pain, and costs. Finding the Prostate Cancer screening stopping age was...
Main Authors: | Azin Nahvijou, Mohammad Hadian, Naser Mohamadkhani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294224000030 |
Similar Items
-
Low Levels of Urinary PSA Better Identify Prostate Cancer Patients
by: Sergio Occhipinti, et al.
Published: (2021-07-01) -
General practitioners’ reflections on using PSA for diagnosis of prostate cancer. A qualitative study
by: Olav Thorsen, et al.
Published: (2022-04-01) -
Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population
by: Yi-Shuo Wu, et al.
Published: (2018-01-01) -
Prostate cancer screening in low- and -middle income countries: the Mexican case
by: Martin Lajous, et al.
Published: (2019-07-01) -
Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey
by: Oktay Uçer, et al.
Published: (2015-10-01)